Edward Bass
Family Medicine · Sylvester, GANPI 1205811262
Payments from drug & device makers
Across 227 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$753
- Lilly USA, LLC$611
- GSK$471
- AstraZeneca$465
- Boehringer Ingelheim$277
- Astellas Pharma US Inc$240
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,092100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $753 |
| Lilly USA, LLC | 42 | $611 |
| GSK | 20 | $471 |
| AstraZeneca | 24 | $465 |
| Boehringer Ingelheim | 14 | $277 |
| Astellas Pharma US Inc | 13 | $240 |
| Johnson & Johnson(2 entities) | 8 | $150 |
| AbbVie | 6 | $116 |
| Bayer | 6 | $112 |
| Merck | 6 | $92 |
| Sumitomo Pharma America, Inc. | 1 | $84 |
| Dexcom, Inc. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Novartis | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Pfizer | 4 | $64 |
| Avanir Pharmaceuticals, Inc. | 3 | $62 |
| Shield Therapeutics Inc | 3 | $47 |
| Exact Sciences | 2 | $41 |
| Abbott | 2 | $39 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Biogen | 1 | $22 |
| Philips North America LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Amgen | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$122
How this compares
$4,112 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 166 | $124,306 |
| OzempicSemaglutide | 100 | $115,541 |
| MounjaroTirzepatide | 60 | $65,520 |
| EliquisApixaban | 87 | $55,300 |
| JanuviaSitagliptin Phosphate | 67 | $48,361 |
| LinzessLinaclotide | 69 | $46,464 |
| RybelsusSemaglutide | 34 | $37,543 |
| XareltoRivaroxaban | 29 | $21,480 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $20,288 |
| MyrbetriqMirabegron | 35 | $18,243 |
| FarxigaDapagliflozin Propanediol | 18 | $17,524 |
| TradjentaLinagliptin | 33 | $16,720 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 648 | $14,295 |
| LivaloPitavastatin Calcium | 23 | $11,221 |
| Bydureon BciseExenatide Microspheres | 13 | $10,474 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $753 | $153,084134 claims |
| Boehringer IngelheimJardiance, Tradjenta | $277 | $141,025199 claims |
| Lilly USA, LLCMounjaro | $611 | $65,52060 claims |
| MerckJanuvia, Janumet Xr | $92 | $57,04382 claims |
| PfizerEliquis | $64 | $55,30087 claims |
| AbbVieLinzess | $116 | $46,46469 claims |
| Johnson & JohnsonXarelto | $150 | $21,48029 claims |
| AstraZenecaFarxiga, Symbicort | $465 | $20,98033 claims |
| GSKTrelegy Ellipta | $471 | $20,28826 claims |
| Astellas Pharma US IncMyrbetriq | $240 | $18,24335 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Sylvester
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.